Treatment of HIV positive patients

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 26, 514934, A61K 3156

Patent

active

059523182

ABSTRACT:
A mixture of betasitosterol and betasitosteryl glycoside in a ratio of between 1:1 and 500:1 is administered to an HIV infected individual. This has the effect of stabilizing CD4 cell numbers, decreasing the plasma viral load, degree of apoptosis in, and the serum levels of 1L6 in the peripheral blood.

REFERENCES:
Xue et al., (AN 93250366, abstract of Chung-Kuo Chung Hsi I Chieh, (1992, Nov.), 12 (11) 652-5.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of HIV positive patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of HIV positive patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of HIV positive patients will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1509856

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.